相关实验视频
Updated: May 3, 2026

13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
23.7K
为脆弱,高风险人群实施特定地点的C型肝炎病毒治疗工作流程:一个潜在的单臂试验
Anmol Desai1, Kia Reinis1, Lauren O'Neal1
1The University of Texas at Austin Dell Medical School, Austin, TX, USA.
Journal of primary care & community health
|March 31, 2025
概括
在脆弱人群中治疗型肝炎病毒 (HCV) 的特定工作流程显示,在护理方面存在重大差距. 需要新的方法来改善这些群体的HCV治疗和治愈率.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 用泛基因型直接作用抗病毒药物治疗C型肝炎病毒 (HCV) 是非常有效的.
- 对于弱势群体来说,获得HCV治疗仍然是一个挑战.
- 简化的治疗算法存在,但并不总是可访问的.
研究的目的:
- 评估特定地点的HCV治疗工作流程对脆弱人群的HCV护理的有效性.
- 在这些工作流程中识别HCV护理级联中的差距.
- 通过RE-AIM框架评估实施情况.
主要方法:
- 预期的,单臂临床试验,涉及诊断为慢性HCV的患者.
- 对参与者进行了治疗处方,启动,完成,治愈评估和治愈成果的评估.
- 用RE-AIM框架来评估实施情况.
主要成果:
- 在62名参与者中,89%的人经历过无家可归,94%的人使用过毒品.
- 治疗处方,启动和完成率分别为66%,49%和38%.
- 只有14%的人被评估为治愈,10%的人实现了治愈.
结论:
- 在招生和治疗处方之间,在治疗完成和治愈评估之间存在显著的差距.
- 网站特定的工作流程不足以充分参与参与者或防止治疗延误.
- 建议采用新的策略,如患者外展,导航,检测和治疗以及解决财务障碍等.
更多相关视频
08:55Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
8.9K
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.2K
相关概念视频
Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
Hepatitis
86
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Viral Hepatitis I: Introduction
25
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25